Guillain-Barré syndrome may be linked to the JNJ COVID-19 vaccine

Guillain-Barré syndrome

The US Food and Drug Administration (FDA) is warning that the Johnson and Johnson (JNJ) COVID-19 vaccine may be linked to Guillain-Barré syndrome, a relatively rare autoimmune disorder. Unfortunately for the confidence in the vaccine, this follows up on several other missteps and potential cardiovascular issues with the vaccine.

Nevertheless, it is clear that the COVID-19 vaccines’ benefits, preventing the disease, far exceed the extremely rare risks.

Because there is a lot of confusion about Guillain-Barré syndrome and whether there is a causal link to the JNJ vaccine, I will try to present the facts as they are known today. Of course, things change, and the CDC’s Advisory Committee on Immunization Practices (ACIP) will meet on 22 July 2021 to further discuss this issue, so stay tuned for more information.

Continue reading “Guillain-Barré syndrome may be linked to the JNJ COVID-19 vaccine”